Exploring the epidemiology of carbapenem-resistant Gram-negative bacteria in west London and the utility of routinely collected hospital microbiology data

被引:29
作者
Freeman, R. [1 ]
Moore, L. S. P. [1 ,2 ]
Charlett, A. [3 ]
Donaldson, H. [2 ]
Holmes, A. H. [1 ,2 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Natl Ctr Infect Prevent & Management, London W12 0NN, England
[2] Imperial Coll Healthcare NHS Trust, London W12 0HS, England
[3] Publ Hlth England, London NW9 5EQ, England
关键词
surveillance; resistance; microbiology; INTENSIVE-CARE-UNIT; KLEBSIELLA-PNEUMONIAE; COMMUNITY; OUTBREAK;
D O I
10.1093/jac/dku500
中图分类号
R51 [传染病];
学科分类号
100201 [内科学];
摘要
Objectives: The objective of this study was to identify carbapenem-resistant organisms using routinely collected local microbiology data and describe the epidemiology of carbapenem resistance in two London teaching hospitals. Methods: Data on inpatients infected or colonized with Gram-negative organisms between March 2009 and February 2012 were extracted. A computer algorithm was developed incorporating internationally recognized criteria to distinguish carbapenem-resistant organisms. Multivariable analysis was conducted to identify factors associated with infection or colonization with carbapenem-resistant organisms. Binomial regression was performed to detect changes in resistance trends over time. Results: Yearly incidence of carbapenem resistance was observed to be increasing, with significant increasing trends in Acinetobacter baumannii (47.1% in 2009-10 to 77.2% in 2011-12; P < 0.001) and Enterobacter spp. (2.2% in 2009-10 to 11.5% in 2011-12; P < 0.001). Single-variable and multivariable analysis demonstrated differences in the proportion of carbapenem-resistant isolates across all variables investigated, including age, sex and clinical specialty; in the latter organism-specific niches were identified. Patients in the youngest age group (16-24 years old) had the highest odds of being infected or colonized with carbapenem-resistant isolates of Escherichia coli, Klebsiella spp. or Pseudomonas aeruginosa. Furthermore, proportions of carbapenem-resistant organisms differed between the hospitals. Conclusions: Carbapenem resistance is an emerging problem within the UK inpatient healthcare setting. This is not an issue confined to the Enterobacteriaceae and fine-resolution surveillance is needed to identify at-risk groups. Regular analysis of routinely collected data can provide insight into the evolving carbapenem-resistance threat, with the ability to inform efforts to prevent the spread of resistance.
引用
收藏
页码:1212 / 1218
页数:7
相关论文
共 23 条
[1]
[Anonymous], GUID CONTR CARB RES
[2]
[Anonymous], 2009, EURO SURVEILL
[3]
[Anonymous], EUCAST GUID DET RES
[4]
[Anonymous], 2013, Current, V114
[5]
BSAC, BSAC METH ANT SUSC T
[6]
KLEBSIELLA PNEUMONIAE CARBAPENEMASE-PRODUCING KLEBSIELLA PNEUMONIAE IN THE INTENSIVE CARE UNIT: A REAL CHALLENGE TO PHYSICIANS, SCIENTIFIC COMMUNITY, AND SOCIETY [J].
Carvalhaes, Cecilia Godoy ;
Cayo, Rodrigo ;
Gales, Ana Cristina .
SHOCK, 2013, 39 (07) :32-37
[7]
Chief Medical Officer, 2013, ANN REP CHIEF MED OF
[8]
Departement of Health, 2013, UK 5 YEAR ANT RES ST
[9]
Advances in electronic surveillance for healthcare-associated infections in the 21st Century: a systematic review [J].
Freeman, R. ;
Moore, L. S. P. ;
Alvarez, L. Garcia ;
Charlett, A. ;
Holmes, A. .
JOURNAL OF HOSPITAL INFECTION, 2013, 84 (02) :106-119
[10]
HPA, WORK PART GUID CONTR